health

Chevron Wins Latest Round in Ecuador Pollution Case

Outside the New York federal courthouse on Oct 15, 2013, Ecuadorians and their supporters gather to protest the Chevron lawsuit. Credit: Samuel Oakford/IPS

WASHINGTON, Mar 5 2014 (IPS) – In the latest twist in a 21-year-old environmental pollution case, a U.S. federal judge Tuesday ruled that the victims of massive oil spillage and their U.S. attorney could not collect on a nine-billion-dollar judgement by Ecuador’s supreme court against the Chevron Corporation.

In a racketeering case brought by the U.S. oil giant, the judge found that the lawyer, Steven Donziger, and his associates had used bribery and falsified evidence to prevail against Chevron in Ecuador’s courts and thus should not be permitted to collect damages.“Misconduct on the part of a couple of lawyers… is not a get-out-of-jail-free card for a corporation that has committed massive toxic contamination.” — Marco Simons

“It is distressing that the course of justice was perverted,” the District Court Judge Lewis Kaplan wrote in a nearly 500-page ruling.

“There is no ‘Robin Hood’ defense to illegal and wrongful conduct,” he went on. “And the defendants’ ‘this-is-the-way-it-is-done-in-Ecuador’ excuses – actually a remarkable insult to the people of Ecuador do not help them.”

Chevron applauded the judgement “as a resounding victory,” while Donziger and his attorneys said they would take the ruling to the same appeals court that overturned a similar judgement in the case rendered by Kaplan in 2011. At that time, Chevron appealed to the U.S. Supreme Court to uphold Kaplan’s original ruling, but the Court rejected the appeal without comment.

Donziger himself called Kaplan’s latest judgement, which followed a six-week trial conducted late last year, “an appalling decision resulting from a deeply flawed proceeding that overturns a unanimous ruling by Ecuador’s Supreme Court. …We are confident we will be fully vindicated in the U.S., as we have been in Ecuador.”

The case was first filed in the U.S. federal court in 1993 on behalf of 30,000 mostly indigenous residents of the Lago Agrio region of the Ecuadorean Amazon where Texaco, which was acquired by Chevron in 2001, had operated continuously from the 1960s until 1992. For much of that period, it worked in partnership with Petroecuador, which took over all of Texaco’s operations in the region when the U.S. oil giant left.
Related IPS Articles

The plaintiffs claim that Texaco dumped more than 70 billion litres of toxic liquids, left some 910 waste pits filled with toxic sludge, and flared millions of cubic metres of toxic gases – poisoning the environment in one of the most biologically diverse areas in South America and creating serious health problems, including an unusually high incidence of cancer, for people living in the region.

Apparently concerned that U.S. courts would be more sympathetic to the plaintiffs’ case, Texaco persuaded Judge Jed Rakoff to have the case transferred to Ecuador in 2002 when it was ruled by a conservative government eager for foreign investment on condition that the company waive certain defences, such as the expiration of the statute of limitations, and ensure that any judgement would be enforceable in the U.S. The Ecuadorean case was filed the following year.

Chevron has long argued that the damages cited by the plaintiffs are exaggerated and that, in any case, Texaco extinguished its obligations when it carried out a 40-million- dollar environmental remediation project as part of a 1995 agreement with the Ecuadorean government that covered 37.5 percent of the well sites and waste pits in the concession area.

The remaining sites were to be cleaned up by Petroecuador, according to Chevron.

But the plaintiffs, who are backed by a number of local and international green groups, have argued that Chevron, having drilled all of the original sites, also remains responsible for Petroecuador’s portion, as well as for the continuing health and other impacts of its operations that are not covered by the 1995 agreement.

The trial court in Ecuador ruled against Chevron and granted the plaintiffs, who were represented by Donziger and his associates, an 18 billion dollar judgement. The country’s Supreme Court subsequent upheld the judgement but reduced the damages to 9.5 billion dollars.

Chevron, however, has sought to prevent the plaintiffs from collecting any of the money, by, among other steps, withdrawing all of its assets from Ecuador and initiating a racketeering suit against Donziger and his team based on its charges that they used bribery and other corrupt methods to win the case and extort billions of dollars from the company.

To sustain those charges, it subpoenaed tens of thousands of documents, emails, and other materials from Donziger and other lawyers, as well as activist groups that supported the case. It even subpoenaed out-takes from a 2009 documentary produced by film-maker Joe Berlinger, “Crude,” about the case.

In his testimony last November, Donziger himself admitted making mistakes, such as concealing his interactions with and payments to a court-appointed expert witness who produced a report on which the Ecuadorean courts relied for the assessment of damages.

One former Ecuadorean judge testified for Chevron that plaintiffs paid him to ghostwrite opinions for the presiding judge who had been promised half a million dollars by Donziger for a favourable ruling. Both Donziger and the presiding judge, Nicolas Zambrano, vehemently denied those charges.

Nonetheless, Kaplan, who has never questioned the extent of the environmental damage wrought by the oil companies’ operations in the region, ruled in favour of Chevron, noting that “an innocent defendant is no more entitled to submit false evidence, to co-opt and pay off a court-appointed expert or to coerce or bribe a judge or jury than a guilty one.” He also noted that Donziger himself stood to win more than 600 million dollars in contingency fees.

If upheld, Kaplan’s ruling would prevent Donziger and the plaintiffs from collecting any damages from Chevron in U.S. courts. It also requires them to turn over any damages against Chevron they might collect in foreign courts to the company.

The plaintiffs have brought cases in three countries where Chevron has major operations and assets Canada, Brazil, and Argentina – to enforce the Ecuadorean judgment, and Chevron’s CEO Tuesday told reporters Tuesday that Kaplan’s ruling should bolster the case in those countries.

The judgement, according to Deepak Gupta, who represented Donziger, amounted to “what is in effect a global anti-collection injunction that would preclude enforcement of a judgement from one country in every jurisdiction.” He noted that was one of the main reasons why the appeals court overturned Kaplan’s 2011 decision.

Marco Simons, legal director of EarthRights International, told IPS Tuesday’s judgement was vulnerable on other grounds as well. He said the law over whether the kinds of injunctions issued by Kaplan could be employed under the federal racketeering law remains unsettled.

In addition, he noted, the fact that Kaplan had found that the Ecuadorean judicial system had not provided due process “offers a good basis for re-filing the substantive case against Chevron in U.S. courts.”

“And even if all of what Judge Kaplan said about the fraudulent conduct of the attorneys was true, the answer shouldn’t necessarily be that Chevron gets away with no liability for what it has done in the Ecuadorean Amazon,” he said. “Misconduct on the part of a couple of lawyers, which is what Judge Kaplan suggested, is not a get-out-of-jail-free card for a corporation that has committed massive toxic contamination.”

 

Related Posts

Innov8: The Future of Healthcare Investing

Innov8 is a company that is revolutionizing the way people invest in healthcare. The company offers top-of-the-range health supplements that are exclusive to the company. These supplements are designed to improve the customer s health and well-being, and they can also help them to earn a significant income. 

How it works 

Innov8 works by providing people with the opportunity to become a distributor of their health supplements. As a distributor, one will be able to sell their products to their friends, family, and colleagues. They will also be able to build a network of distributors under them, and they will earn a commission on all of the products that they sell. 

The benefits of becoming a distributor 

There are many benefits to becoming a distr…

Fitness Psychology: 4 Strategies For Achieving Goals

Achieving is not just about lifting weights, running faster, or mastering complex yoga poses. While these physical achievements are significant, they are only one side of the coin. The other side, often less talked about but equally important, is the fitness psychological aspect. This involves harnessing the power of your mind to propel you toward your fitness goals.

Psychology of fitness

The mind plays a pivotal role in . It s the driving force that gets you out of bed for an early morning run, pushes you to complete that last set of squats, and helps you stay committed to your diet. Succumbing to laziness, procrastination, or discouragement is accessible without a solid mental foundation.

Understanding the psychological aspects of fitness is crucia…

The Role of Health Tech Consulting in Transforming Healthcare

In today s quickly changing healthcare environment, the role of has become increasingly vital. Healthcare organizations are constantly striving to enhance patient care, improve operational efficiency, and stay ahead in an ever-competitive market. This article delves into the significance of health tech consulting and how it is revolutionizing the healthcare industry.

Advancing Healthcare Through Technology

Health tech consulting, often referred to as healthcare technology consulting, plays a pivotal role in leveraging cutting-edge technology to advance healthcare services. This sector focuses on integrating innovative solutions and digital tools to streamline processes, enhance patient outcomes, and reduce costs.

Enhancing Patient Care

One of the pr…

The Future of Medical Note-Taking: Dictaphone Stethoscope Style

In the ever-evolving field of healthcare, advancements in technology continue to shape the way medical professionals operate. One such innovation that promises to revolutionize the way doctors and nurses take notes is the Stethoscope. This combination of traditional and cutting-edge technologies holds the potential to streamline patient care, improve accuracy, and enhance overall efficiency in healthcare settings.

The Evolution of Medical Note-Taking

Medical note-taking is an essential aspect of patient care. Accurate and comprehensive notes are crucial for tracking patient history, ensuring proper diagnosis, and providing optimal treatment. Traditionally, healthcare providers relied on handwritten notes, which could be time-consuming and prone to errors. How…

Unleashing the Smile Revolution: Unveiling the Advantages of Dental Care in Mexico

 

Introduction:

Are you tired of paying exorbitant prices for quality dental care? Look no further than , a burgeoning hub for dental tourism that offers a wealth of advantages compared to other countries. Nestled on the US-Mexico border, Tijuana shines as a prime destination, attracting patients seeking affordable excellence. Join us as we delve into the unparalleled advantages of receiving dental care in Mexico, revolutionizing the way you approach dental treatments.

1. Cost-Effective Excellence:

One of the paramount advantages of choosing Mexico for dental care is the significant cost savings compared to other countries. The skyrocketing costs of dental treatments have become a major concern for patients worldwide. However, Mexico offers a co…

Targeting Tumor Suppression Pathways IN LUNG CANCER: Genprex’s take on precision medicine

Lung cancer continues to be a stark reality in the global health conversation, relentlessly claiming lives and leaving a trail of despair. In the U.S. alone, over 238,000 new lung cancer cases are anticipated in 2023, with a slightly higher incidence in women than men. Even more alarming, nearly 48,000 non-smokers in the U.S. are expected to be diagnosed in 2023. These grim statistics underscore the dire need for innovative treatments. , a leading biopharmaceutical firm, is stepping up to this challenge, aiming to develop cutting-edge therapies targeting tumor suppression pathways​.

The Promise of Gene Therapy

Gene therapy holds great promise in revolutionizing the treatment of various diseases and conditions. With its ability to target specific genetic def…

Leave a Reply

Your email address will not be published. Required fields are marked *